Quantcast
Last updated on April 18, 2014 at 14:46 EDT

Latest CHEK2 Stories

2013-10-09 23:24:00

In honor of Breast Cancer Awareness Month, Fertility Centers of Illinois discusses genetic screening for breast cancer and fertility preservation during a breast cancer diagnosis. Chicago, IL (PRWEB) October 09, 2013 For some families with the BRCA1 gene mutation, the lifetime risk of breast cancer can be as high as 80 percent, with the average risk of breast cancer resulting from a BRCA1 or BRCA2 gene mutation ranging from 45 to 65 percent. Through advances in modern science, couples are...

2009-09-22 09:31:51

U.S. researchers say they've discovered cancer predisposition resulting from the presence of a specific gene variant shows a strong gender bias. University of Cincinnati Professor Peter Stambrook, who led the study, said the gene CHEK2 is part of a DNA damage response pathway that can have an impact on whether cancers develop. A CHEK2 variant, is associated with increased risk of cancer. Women who carry this particular gene variant are predisposed to developing breast or ovarian cancer,...

2009-09-22 07:31:20

Cancer predisposition resulting from the presence of a specific gene variant shows a strong gender bias, researchers at the University of Cincinnati (UC) have demonstrated. In addition, the research indicates that the risk for development of cancer in individuals harboring the gene variant can be further increased as a result of environmental exposure. Peter Stambrook, PhD, a professor in the department of molecular genetics, biochemistry and microbiology, and colleagues report their findings...

2006-03-22 14:55:00

By Karla Gale NEW YORK (Reuters Health) - Commercial genetic testing does not detect all of the cancer-associated inherited mutations in women with an extensive family history of breast or ovarian cancer, according to a study in the Journal of the American Medical Association. "Women who were familial breast cancer patients were being commercially tested for inherited mutations in BRCA1 and BRCA2, and a very large number had reports returned that said they had negative results," Dr....